Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) EBT: 2009-2025

Historic EBT for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $98.5 million.

  • BIO-TECHNE's EBT rose 19.47% to $48.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.3 million, marking a year-over-year decrease of 39.72%. This contributed to the annual value of $98.5 million for FY2025, which is 46.97% down from last year.
  • BIO-TECHNE's EBT amounted to $98.5 million in FY2025, which was down 46.97% from $185.7 million recorded in FY2024.
  • BIO-TECHNE's EBT's 5-year high stood at $338.7 million during FY2023, with a 5-year trough of $98.5 million in FY2025.
  • Its 3-year average for EBT is $207.6 million, with a median of $185.7 million in 2024.
  • Its EBT has fluctuated over the past 5 years, first surged by 103.40% in 2022, then tumbled by 46.97% in 2025.
  • Over the past 5 years, BIO-TECHNE's EBT (Yearly) stood at $148.2 million in 2021, then surged by 103.40% to $301.4 million in 2022, then grew by 12.37% to $338.7 million in 2023, then crashed by 45.17% to $185.7 million in 2024, then slumped by 46.97% to $98.5 million in 2025.